Core Insights - Sinopec (Dalian) Petrochemical Research Institute is recruiting for 11 positions in key areas such as solid-state batteries, petrochemical artificial intelligence, bio-based monomers and materials, and synthetic biology, offering attractive annual salaries ranging from 500,000 to 2,000,000 CNY and 10 million CNY in research startup funding [1]. Group 1: Recruitment Details - The recruitment focuses on experts in synthetic biology, petrochemical engineering plastics, and bio-based monomers and materials [2][3][4]. - Each position requires a PhD, candidates aged between 30-50 years, and a minimum of 10 years of relevant work experience, with flexibility for outstanding candidates [5][5][5]. Group 2: Job Responsibilities and Requirements - Responsibilities include formulating strategic plans for carbon gas bioconversion, developing strain modification and biocatalysis systems, and leading product development and market promotion [5]. - The positions also involve planning the development strategy for special engineering plastics and bio-based materials, with a focus on technology development and market promotion [5][5][5]. Group 3: Compensation and Benefits - The salary range is between 500,000 to 2,000,000 CNY per year, with additional relocation allowances of 1.2 to 5 million CNY for high-level talent [7]. - The company provides 10 million CNY in research startup funding, a well-equipped research team of 3-8 members, and various support for relocation, education, and employment for family members [7]. Group 4: Upcoming Events - The 4th Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22, 2025, in Ningbo, Zhejiang, focusing on AI and bio-manufacturing, green chemicals, new materials, future food, agriculture, and beauty raw materials [8]. - The conference aims to explore the development trends in the bio-manufacturing industry and promote the transfer and transformation of scientific achievements [8].

SynBioCon 大会 | 致力于科技成果转化 DT新材料致力于科技成果转移转化。SynBioCon大会聚焦产业生态发展与科技成果转移转化，已完成1000+次科研院所和初创项目对接。本届大会 同期将继续举办 特色活动 「合成生物制造创新科技成果展示与对接 」 ， 收集并 展示100个0~100的合成生物制造创新科技成果 ， 以 促进行 业高效科技成果与转化。 SynBioCon大会持续发布科技成果。本期介绍项目如下： 第四届合成生物与绿色生物制造大会 (简称：SynBioCon 2025) 将于 8月20-22日 在 浙江·宁波 举办，由DT新材料主办，酶赛生物协办，中国 生物工程学会生物基材料专业委员会、上海市未来产业生物制造专委会、广州合成生物产学研技术创新联盟共同支持 。 成果名称 微藻基硒蛋白的合成 成果简介 硒是动物和人类必需的微量元素，由于我国人民对硒的摄入长期不足，导致人们"硒隐性饥饿"问题严重。研究发现硒蛋白是人民补硒的理想硒源，但 粮食、蔬菜和水果等高等植物不含硒蛋白，而可食微藻含有丰富的硒蛋白，拥有合成硒蛋白的能力。因此，以富硒可食微藻为底盘异源合成硒蛋白将 是实现我国"全民科学补硒"的 ...

Core Viewpoint - The era of producing high-value products from CO₂ in the air has arrived, marking significant industrial advancements in the biomanufacturing conversion of carbon-rich gases [1][2]. Group 1: Industrial Challenges and Innovations - The Ministry of Agriculture and Rural Affairs of China has officially approved the use of Debaryomyces hansenii protein as a new feed raw material, representing the first product certificate with independent intellectual property rights derived from CO₂ as the main carbon source [2][4]. - This approval signifies a critical step in the industrial application of this technology, transitioning from laboratory research to practical use [2][4]. - The gas fermentation technology developed by GTLB utilizes inorganic carbon sources (CO₂, CO) to convert them into organic products, overcoming significant industrial challenges [4][6]. Group 2: Production Efficiency and Nutritional Value - The feed protein produced using this gas fermentation technology can achieve production efficiency thousands of times higher than traditional agricultural methods [7]. - A yeast protein factory occupying 150 acres can produce 100,000 tons of high-quality yeast protein annually, equivalent to the output of approximately 600,000 acres of soybean protein [8]. - Yeast protein is recognized for its high and evenly distributed essential amino acid content, rich in trace elements and polysaccharides, making it a safe and high-quality protein source [9]. Group 3: Addressing Resource Shortages - China faces a severe shortage of feed protein resources, with an estimated total consumption of 70 million tons in 2024 and an import dependency exceeding 80%, posing a significant threat to national food security [11]. - The innovative technology aligns with national strategies to develop synthetic biology technologies and explore "artificial protein" as a new food source, aiming to reduce reliance on traditional protein sources like soybean and fishmeal [12]. - The approval of Debaryomyces hansenii protein as a single feed raw material will help create a more sustainable and resource-efficient protein feed supply chain, significantly reducing dependence on land-intensive crops and marine resources [12].

Core Insights - The "14th Five-Year Plan" has concluded, and the "15th Five-Year Plan" is being formulated, highlighting a clear and distinct evolution in China's strategic layout in the field of biomanufacturing [1] Group 1: Development Goals - The "15th Five-Year Plan" is a critical period for the comprehensive rise of China's biomanufacturing industry, with a key goal of achieving an added value of over 4 trillion yuan in advanced biomanufacturing and related services, and a biomanufacturing penetration rate exceeding 8% [3] Group 2: Industry Structure - The plan aims to establish three major systems: innovation, industry, and management services, accelerating the development of a "7+1" biomanufacturing industry system, which includes biopharmaceuticals, bio-based chemicals and materials, bioenergy, fermentation, bioengineering food, animal feed, biotechnology equipment, and bio-services [4] Group 3: Future Opportunities - The upcoming SynBioCon 2025 conference will focus on the intersection of AI and biomanufacturing, exploring trends in green chemicals, new materials, future food, future agriculture, and beauty raw materials, while inviting international leading companies and experts to discuss innovative technologies and products that will sustain the vitality of the biomanufacturing industry [14]

浙江省合成生物产业技术联盟 将作为 8月20-22日在浙江·宁波 举办的 SynBioCon 2025第四届合成生物绿色生物制造大会 的「 支持单位 」之一。同时， 浙江大学杭州国 际科创中心 姚远教授 将出席 「 AI+生物智造 」专场。 2025年初，浙江省经济和信息化厅 正式公布 《浙江省加快合成生物产业创新发展的实施方案》 ，该方案 涉 及 合成生物学与绿色生物制造 6 大发展方向 、 浙江 11 大地区产业布局 、 浙江 9 大高校和科研院所 重点任务、10大核心技术攻关 。同时，方案目标规划 合成生物核心企业产值达200亿元，相关产业总规模 达1500亿元 ，形成具有国际影响力的合成生物产业创新发展高地。 点击更多阅读 ： 到2027年总规模达1500亿！浙江省加快合成生物产业创新发展方案印发！ 浙江省合成生物产业技术联盟 （简称"联盟"）是浙江省经济和信息化厅指导，经省经信厅正式批准，由 浙 江大学杭州国际科创中心 牵头，联合浙江省合成生物产业链相关链主企业、高科技企业、科研院所等共同 发起成立的跨行业、开放性的非营利组织。 联盟将充分发挥浙江大学杭州国际科创中心在 人才培育、技术创新、高能级平 ...

【SynBioCon】 获 悉 ，近期， 浙江工业大学郑裕国院士团队柳志强教授课题组 采用模块化途径工程、酶筛选、sRNA 引导的瓶颈识别、微调关键代谢节点、辅因子工程和发酵优化等系统代谢工程策略，开发了一种无质粒、无营养缺陷的 OAH高产菌株OAH37，将OAH发酵产量增产至 94.1 g/L ，创目前报道最高纪录，为OAH的绿色生物制造奠定了坚实基 础。 图1 OAH的代谢途径及其增产策略示意图 主要研究内容及其关键技术突破： 1. 「L-高丝氨酸+MetX」双模块加强，促进OAH初步积累 团队以前期构建的L-高丝氨酸生产菌株HSY6为底盘，通过质粒引入MetX确定该底盘具备OAH合成能力，产量为5.29 g/L。随后，回补了L-赖氨酸和甲硫氨酸途径，以减少菌株的营养缺陷；进一步整合天冬氨酸转氨酶（ aspB cg ）、谷氨 酸合酶（ gltAB bs ）和天冬氨酸激酶（ lysC pa ），以增强L-高丝氨酸模块的代谢通量。通过异源MetX的筛选，发现来 源于海洋环状菌（ Cyclobacterium marinum ）的 metX cm 整合至假基因位点可将产量提升至8.30 g/L，相较于初始菌 株 ...

Core Viewpoint - The article emphasizes the importance of biomanufacturing as a key focus for enhancing economic competitiveness in various countries, including China, which is advancing its manufacturing capabilities through initiatives like green manufacturing and intelligent manufacturing [1]. Group 1: Event Overview - The Fourth Synthetic Biology and Green Biomanufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on the integration of AI and biomanufacturing [1]. - The conference aims to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan and identify innovative technologies and products that will sustain the industry's vitality [1]. Group 2: Organizing Institutions - The conference is organized by Ningbo Detai Zhongyan Information Technology Co., Ltd. (DT New Materials) and co-organized by Ningbo Meisai Biological Engineering Co., Ltd. [2]. Group 3: Highlights of the Conference - The conference will feature forums and closed-door activities to gain insights into the development trends of biomanufacturing during the 14th Five-Year Plan, exploring new products, technologies, and collaborations [4]. - There will be over 100 financing project roadshows to discover new cooperation opportunities [4]. - Key industry leaders, top universities, and capital from industrial parks will gather to discuss advancements in the biomanufacturing sector [4]. Group 4: Agenda and Special Activities - The first day will include a closed-door seminar focusing on the development trends and growth points of biomanufacturing, inviting 30 industry leaders and experts for in-depth discussions [7]. - The second and third days will feature a macro forum on biomanufacturing, covering the development trends and progress of policies related to the industry [10]. Group 5: Specialized Forums - The conference will host specialized forums on various topics, including green chemicals and new materials, AI in biomanufacturing, future food and agriculture, and beauty raw materials [11]. - Each forum will address specific themes such as the development of bio-based chemicals, green manufacturing technologies, and the application of AI in biomanufacturing processes [11].

Core Viewpoint - The article highlights the recent developments of Inner Mongolia Ruifen Biotechnology Co., Ltd., including the establishment of a new production base for functional sugar alcohols, which signifies a technological breakthrough in the field of functional sweeteners [1][2]. Company Overview - Ruifen Biotechnology, founded in 2007, is a national high-tech enterprise focused on the research and production of natural health food ingredients. The company aims to provide innovative and convenient solutions for the food, beverage, and nutritional supplement industries, emphasizing health, natural ingredients, and high technology [5]. Project Details - The new project involves an investment of 300 million yuan to build a production base with an annual capacity of 30,000 tons of functional sugar alcohols. The project includes the construction of various facilities such as a comprehensive building, R&D center, warehouses, workshops, and energy supply systems [2]. - A cooperation agreement was signed on April 26 between Hohhot Economic and Technological Development Zone and Ruifen Biotechnology for a project with a total investment of approximately 400 million yuan, which will be developed in two phases. The first phase will cover 120 acres and is scheduled to start construction in June 2023, with completion expected by November 2025 and production commencing in March 2026 [4]. Technological Advancements - Ruifen Biotechnology has become the third company in China to obtain approval for D-allohexose-3-epimerase, marking a significant technological advancement in the legal production of allohexose. The company has achieved self-controlled enzyme catalysis technology, which is a critical aspect of its production process [2].

Core Viewpoint - Shougang Longze Technology Co., Ltd. has delayed its global offering and listing plan, returning application funds, originally scheduled for July 9 on the Hong Kong Stock Exchange [1][2]. Company Overview - Shougang Longze focuses on the carbon capture, utilization, and storage (CCUS) industry, producing low-carbon products such as ethanol and microbial protein, and providing comprehensive low-carbon solutions [4]. - The company’s ethanol can be used as fuel and as a raw material for various products, while its microbial protein is the first novel feed protein raw material in China [4]. Financial Performance - In the previous year, Shougang Longze reported revenue of 560 million RMB, a year-on-year decline of 4.9%, with a net loss attributable to shareholders of 140 million RMB, an increase of 1.1 times [6]. - Financial projections indicate a revenue increase to 592.6 million RMB in 2023, followed by a slight decrease to 563.6 million RMB in 2024 [7]. Fund Utilization Plan - The company plans to allocate approximately 37.9% of the net proceeds for the construction and development of SAF production facilities in Baotou, Inner Mongolia, 21.2% for the second phase facility in Hebei, and 11.4% for research and development of strains, production equipment, and smart production management systems [8].

在 "十四五" 规划收官与 "十五五" 规划谋篇布局的历史节点，我国在生物制造领域的战略布局已然彰显出清晰且鲜明的阶段性演进特质。 那么， "十五五" 规划之下，释放哪些生物制造产业新信号？ 【SynBioCon】 获 悉，近日，赛迪研究院消费品工业研究所在2025赛迪论坛上发布 《"十五五"时期我国生物制造产业发展思路》报告 ，该 报告由赛迪研究院消费品工业研究所所长李博洋分享。 报 告指出，"十五五"是我国生物制造全面崛起的关键时期。其 重要目标 是 先进生物制造产业及相关服务业增加值超4万亿元，生物制造渗透 率达到8% 以上，产业迈向中高端发展 。 "十五五"时期要构建创新+产业+管理服务等三大体系，加快发展 "7+1"生物制造产业体系 ，包括 生物医药、生物基化学品和材料、生物能 源、生物发酵、生物工程食品、生物饲料、生物技术装备和生物服务 。 以下是报告部分内容： 请扫码填写 信息，可下载全部报告 | ▌ 参考信息： 文报告 来 | 本 | 自赛迪研究院 。由 | 作 | 者重新 | 编写，系作者个人观 | | --- | --- | --- | --- | --- | --- | | 点，本平台发 ...